<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="44755" whole_study_id="26285" phs="001608" v="3" p="1" createDate="2021-10-25T12:20:49-05:00" modDate="2022-01-25T16:16:33-05:00" maxParentChildStudyModDate="2022-01-25T16:16:33-05:00" handle="TOPMed_WGS_OMG_SCD" num_participants="650"><StudyInfo accession="phs001608.v3.p1" parentAccession="phs001608.v3.p1"><BioProject id="PRJNA472122" entrez_id="472122" type="bp_admin_access"/><BioProject id="PRJNA472123" entrez_id="472123" type="bp_data_submission"/><StudyNameEntrez>NHLBI TOPMed: Outcome Modifying Gene in SCD (OMG-SCD)</StudyNameEntrez><StudyTypes2 calculated="No"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="cloud_for_sequence"/><StudyType22 name="whole_targ_genome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"><StudyType22 name="genotype_calls_from_sequence"/></StudyType21><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="germline"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>sra</StudyType></StudyTypes><SraStorages/></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="TELEN002" aid="2" auth="eRA" login="TELEN002" fname="MARILYN" mname="" lname="TELEN" email="marilyn.telen@duke.edu"><Role>PI</Role><Organization>DUKE UNIVERSITY</Organization></Person><Person nedid="0010146704" aid="1" auth="cit" login="qasbap" fname="Pankaj" mname="" lname="Qasba" email="qasbap@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="AAK001" aid="2" auth="eRA" login="AAK001" fname="ALLISON" mname="" lname="ASHLEY-KOCH" email="Allison.ashleykoch@duke.edu"><Role>PI_ASSIST</Role><Organization>DUKE UNIVERSITY</Organization></Person><Person nedid="0011276160" aid="1" auth="cit" login="thomsonal" fname="Alastair" mname="Alexander" lname="Thomson" email="alastair.thomson@nih.gov"><Role>PI_AA_DELEG</Role><Organization>NIH</Organization></Person><Person nedid="0014418323" aid="1" auth="cit" login="dzakpasuns" fname="Noble" mname="Senyo" lname="Dzakpasu" email="dzakpasuns@mail.nih.gov"><Role>PI_AA_DELEG</Role><Organization>NIH</Organization></Person><Person nedid="GROSSMANR" aid="2" auth="eRA" login="GROSSMANR" fname="ROBERT" mname="" lname="GROSSMAN" email="rgrossman1@uchicago.edu"><Role>PI_AA_DELEG</Role><Organization>UNIVERSITY OF ILLINOIS AT CHICAGOUNIVERSITY OF CHICAGO</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2001545300" aid="1" auth="cit" login="lic17" fname="Chengyuan" mname="" lname="Press" email="chanel.press@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>The TOPMed acknowledgement statement can be found at: https://topmed.nhlbi.nih.gov/acknowledgements.  In addition, please include: "Outcome Modifying Genes in Sickle Cell Disease (OMG-SCD)" was supported by National Institutes of Health (NIH) National Heart, Lung, Blood Institute: R01 HL068959, R01 HL079915, and RC2 HL101212. Authorized access to genotype data may be obtained through accession number phs001608. The authors wish to give special recognition to the individual study participants who provided biological samples and data, without which none of this work would be possible.&#8221;</acknowledgement_statement><ic_specific_access_term>Use of the data must be related to the specified disease - Sickle Cell Disease.
Requestor must provide documentation of local IRB approval.
Requestor agrees to make results of studies using the data available to the larger scientific community.
Requestor must provide a letter of collaboration with the primary study investigator(s).
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms)
Use of the data is limited to genetic studies of the specified disease and related conditions, such as
hemoglobinopathies, anemias and transfusion.
</ic_specific_access_term><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="contr_access" gsr_mode_label="Controlled-access (GSR are sensitive according to the Institutional Certification)"/><ConsentGroup uid="2688" CGType="cg_class_DS" title="Disease-Specific (Sickle Cell Disease, IRB, PUB, COL, MDS, RD)" name="DS-SCD-IRB-PUB-COL-MDS-RD" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes" collaboration-required="Yes"><Use-Restriction>Use of the data must be related to Sickle Cell Disease and related disorders.
Requestor must provide documentation of local IRB approval.
Requestor agrees to make results of studies using the data available to the larger scientific community.
Requestor must provide a letter of collaboration with the primary study investigator(s).
Use of the data includes methods development research (e.g., development of software or algorithms).

</Use-Restriction></ConsentGroup><ConsentGroup uid="2689" CGType="cg_class_EA" title="Exchange Area (IRB, PUB, COL, MDS, RD)" name="EA-IRB-PUB-COL-MDS-RD" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes" collaboration-required="Yes"><Use-Restriction>Use by NHLBI WGS study investigators only.  
There is one consent group: DS-SCD-IRB-PUB-COL-MDS-RD.  
Use of the data must be related to Sickle Cell Disease and related disorders.  
Requestor must provide documentation of local IRB approval.  
Requestor agrees to make results of studies using the data available to the larger scientific community.  
Requestor must provide a letter of collaboration with the primary study investigator(s).  
Use of the data includes methods development research (e.g., development of software or algorithms).
</Use-Restriction></ConsentGroup><TrustedPartners><TrustedPartner trp_id="11" trp_db_name="NHLBI BioData Catalyst" trp_download_url="https://biodatacatalyst.nhlbi.nih.gov/resources/data" trp_help_url="https://biodatacatalyst.nhlbi.nih.gov/contact"><StudyFlags sam_with_min_meta="Yes" seq_data_to_ncbi="Yes" gen_phen_to_ncbi="Yes" has_out_ncbi_data="Yes"/></TrustedPartner></TrustedPartners></Policy><SRA/><Documents/><Status uid="2" name="complete" title="Awaiting GPA's Approval"/></Study><Study uid="38332" whole_study_id="26285" phs="001608" v="2" p="1" createDate="2020-04-28T14:35:27-05:00" completedByGPADate="2021-05-19T09:26:20-05:00" modDate="2022-01-25T16:16:22-05:00" maxParentChildStudyModDate="2022-01-25T16:16:22-05:00" handle="TOPMed_WGS_OMG_SCD" num_participants="650"><StudyInfo accession="phs001608.v2.p1" parentAccession="phs001608.v2.p1"><BioProject id="PRJNA472122" entrez_id="472122" type="bp_admin_access"/><BioProject id="PRJNA472123" entrez_id="472123" type="bp_data_submission"/><StudyNameEntrez>NHLBI TOPMed: Outcome Modifying Gene in SCD (OMG-SCD)</StudyNameEntrez><StudyTypes2 calculated="No"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="cloud_for_sequence"/><StudyType22 name="whole_targ_genome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"><StudyType22 name="genotype_calls_from_sequence"/></StudyType21><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="germline"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>sra</StudyType></StudyTypes><SraStorages/></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="TELEN002" aid="2" auth="eRA" login="TELEN002" fname="MARILYN" mname="" lname="TELEN" email="marilyn.telen@duke.edu"><Role allow_direct_access="true">PI</Role><Organization>DUKE UNIVERSITY</Organization></Person><Person nedid="0010146704" aid="1" auth="cit" login="qasbap" fname="Pankaj" mname="" lname="Qasba" email="qasbap@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="AAK001" aid="2" auth="eRA" login="AAK001" fname="ALLISON" mname="" lname="ASHLEY-KOCH" email="Allison.ashleykoch@duke.edu"><Role>PI_ASSIST</Role><Organization>DUKE UNIVERSITY</Organization></Person><Person nedid="0011276160" aid="1" auth="cit" login="thomsonal" fname="Alastair" mname="Alexander" lname="Thomson" email="alastair.thomson@nih.gov"><Role>PI_AA_DELEG</Role><Organization>NIH</Organization></Person><Person nedid="0014418323" aid="1" auth="cit" login="dzakpasuns" fname="Noble" mname="Senyo" lname="Dzakpasu" email="dzakpasuns@mail.nih.gov"><Role>PI_AA_DELEG</Role><Organization>NIH</Organization></Person><Person nedid="GROSSMANR" aid="2" auth="eRA" login="GROSSMANR" fname="ROBERT" mname="" lname="GROSSMAN" email="rgrossman1@uchicago.edu"><Role>PI_AA_DELEG</Role><Organization>UNIVERSITY OF ILLINOIS AT CHICAGOUNIVERSITY OF CHICAGO</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2001545300" aid="1" auth="cit" login="lic17" fname="Chengyuan" mname="" lname="Press" email="chanel.press@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>The TOPMed acknowledgement statement can be found at: https://topmed.nhlbi.nih.gov/acknowledgements.  In addition, please include: "Outcome Modifying Genes in Sickle Cell Disease (OMG-SCD)" was supported by National Institutes of Health (NIH) National Heart, Lung, Blood Institute: R01 HL068959, R01 HL079915, and RC2 HL101212. Authorized access to genotype data may be obtained through accession number phs001608. The authors wish to give special recognition to the individual study participants who provided biological samples and data, without which none of this work would be possible.&#8221;</acknowledgement_statement><ic_specific_access_term>Use of the data must be related to the specified disease - Sickle Cell Disease.
Requestor must provide documentation of local IRB approval.
Requestor agrees to make results of studies using the data available to the larger scientific community.
Requestor must provide a letter of collaboration with the primary study investigator(s).
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms)
Use of the data is limited to genetic studies of the specified disease and related conditions, such as
hemoglobinopathies, anemias and transfusion.
</ic_specific_access_term><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="contr_access" gsr_mode_label="Controlled-access (GSR are sensitive according to the Institutional Certification)"/><ConsentGroup uid="2688" CGType="cg_class_DS" title="Disease-Specific (Sickle Cell Disease, IRB, PUB, COL, MDS, RD)" name="DS-SCD-IRB-PUB-COL-MDS-RD" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes" collaboration-required="Yes"><Use-Restriction>Use of the data must be related to Sickle Cell Disease and related disorders.
Requestor must provide documentation of local IRB approval.
Requestor agrees to make results of studies using the data available to the larger scientific community.
Requestor must provide a letter of collaboration with the primary study investigator(s).
Use of the data includes methods development research (e.g., development of software or algorithms).

</Use-Restriction></ConsentGroup><ConsentGroup uid="2689" CGType="cg_class_EA" title="Exchange Area (IRB, PUB, COL, MDS, RD)" name="EA-IRB-PUB-COL-MDS-RD" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes" collaboration-required="Yes"><Use-Restriction>Use by NHLBI WGS study investigators only.  
There is one consent group: DS-SCD-IRB-PUB-COL-MDS-RD.  
Use of the data must be related to Sickle Cell Disease and related disorders.  
Requestor must provide documentation of local IRB approval.  
Requestor agrees to make results of studies using the data available to the larger scientific community.  
Requestor must provide a letter of collaboration with the primary study investigator(s).  
Use of the data includes methods development research (e.g., development of software or algorithms).
</Use-Restriction></ConsentGroup><TrustedPartners><TrustedPartner trp_id="11" trp_db_name="NHLBI BioData Catalyst" trp_download_url="https://biodatacatalyst.nhlbi.nih.gov/resources/data" trp_help_url="https://biodatacatalyst.nhlbi.nih.gov/contact"><StudyFlags sam_with_min_meta="Yes" seq_data_to_ncbi="Yes" gen_phen_to_ncbi="Yes" has_out_ncbi_data="Yes"/></TrustedPartner></TrustedPartners></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="26285" whole_study_id="26285" phs="001608" v="1" p="1" createDate="2017-08-01T16:49:48-05:00" completedByGPADate="2017-08-04T14:27:09-05:00" modDate="2020-09-01T10:55:46-05:00" maxParentChildStudyModDate="2020-09-01T10:55:46-05:00" handle="TOPMed_WGS_OMG_SCD" num_participants="650"><StudyInfo accession="phs001608.v1.p1" parentAccession="phs001608.v1.p1"><BioProject id="PRJNA472122" entrez_id="472122" type="bp_admin_access"/><BioProject id="PRJNA472123" entrez_id="472123" type="bp_data_submission"/><StudyNameEntrez>NHLBI TOPMed: Outcome Modifying Gene in SCD (OMG-SCD)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="cloud_for_sequence"/><StudyType22 name="whole_targ_genome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="germline"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType><StudyType>germline</StudyType><StudyType>whole_genome</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages/></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="true" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="TELEN002" aid="2" auth="eRA" login="TELEN002" fname="MARILYN" mname="" lname="TELEN" email="marilyn.telen@duke.edu"><Role allow_direct_access="true">PI</Role><Organization>DUKE UNIVERSITY</Organization></Person><Person nedid="0010146704" aid="1" auth="cit" login="qasbap" fname="Pankaj" mname="" lname="Qasba" email="qasbap@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="AAK001" aid="2" auth="eRA" login="AAK001" fname="ALLISON" mname="" lname="ASHLEY-KOCH" email="Allison.ashleykoch@duke.edu"><Role>PI_ASSIST</Role><Organization>DUKE UNIVERSITY</Organization></Person><Person nedid="0011276160" aid="1" auth="cit" login="thomsonal" fname="Alastair" mname="Alexander" lname="Thomson" email="alastair.thomson@nih.gov"><Role>PI_AA_DELEG</Role><Organization>NIH</Organization></Person><Person nedid="0014418323" aid="1" auth="cit" login="dzakpasuns" fname="Noble" mname="Senyo" lname="Dzakpasu" email="dzakpasuns@mail.nih.gov"><Role>PI_AA_DELEG</Role><Organization>NIH</Organization></Person><Person nedid="GROSSMANR" aid="2" auth="eRA" login="GROSSMANR" fname="ROBERT" mname="" lname="GROSSMAN" email="rgrossman1@uchicago.edu"><Role>PI_AA_DELEG</Role><Organization>UNIVERSITY OF ILLINOIS AT CHICAGOUNIVERSITY OF CHICAGO</Organization></Person><Person nedid="0013269007" aid="1" auth="cit" login="kianga" fname="Anne" mname="" lname="Sturcke" email="kianga@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2000452640" aid="1" auth="cit" login="chensh2" fname="Shu Hui" mname="" lname="Chen" email="shuhui.chen@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>The TOPMed acknowledgement statement can be found at: https://www.nhlbiwgs.org/acknowledgements.  In addition, please include: "Outcome Modifying Genes in Sickle Cell Disease (OMG-SCD)" was supported by National Institutes of Health (NIH) National Heart, Lung, Blood Institute: R01 HL068959, R01 HL079915, and RC2 HL101212. Authorized access to genotype data may be obtained through accession number phs001608. The authors wish to give special recognition to the individual study participants who provided biological samples and data, without which none of this work would be possible.&#8221;</acknowledgement_statement><ic_specific_access_term>Use of the data must be related to the specified disease - Sickle Cell Disease.
Requestor must provide documentation of local IRB approval.
Requestor agrees to make results of studies using the data available to the larger scientific community.
Requestor must provide a letter of collaboration with the primary study investigator(s).
Use of the data is limited to not-for-profit organizations.
Use of the data includes methods development research (e.g., development of software or algorithms)
Use of the data is limited to genetic studies of the specified disease and related conditions, such as
hemoglobinopathies, anemias and transfusion.
</ic_specific_access_term><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="contr_access" gsr_mode_label="Controlled-access (GSR are sensitive according to the Institutional Certification)"/><ConsentGroup uid="2688" CGType="cg_class_DS" title="Disease-Specific (Sickle Cell Disease, IRB, PUB, COL, MDS, RD)" name="DS-SCD-IRB-PUB-COL-MDS-RD" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes" collaboration-required="Yes"><Use-Restriction>Use of the data must be related to Sickle Cell Disease and related disorders.
Requestor must provide documentation of local IRB approval.
Requestor agrees to make results of studies using the data available to the larger scientific community.
Requestor must provide a letter of collaboration with the primary study investigator(s).
Use of the data includes methods development research (e.g., development of software or algorithms).

</Use-Restriction></ConsentGroup><ConsentGroup uid="2689" CGType="cg_class_EA" title="Exchange Area (IRB, PUB, COL, MDS, RD)" name="EA-IRB-PUB-COL-MDS-RD" dac_uid="56" dac_name="NHLBI" irb-approval-required="Yes" collaboration-required="Yes"><Use-Restriction>Use by NHLBI WGS study investigators only.  
There is one consent group: DS-SCD-IRB-PUB-COL-MDS-RD.  
Use of the data must be related to Sickle Cell Disease and related disorders.  
Requestor must provide documentation of local IRB approval.  
Requestor agrees to make results of studies using the data available to the larger scientific community.  
Requestor must provide a letter of collaboration with the primary study investigator(s).  
Use of the data includes methods development research (e.g., development of software or algorithms).
</Use-Restriction></ConsentGroup><TrustedPartners><TrustedPartner trp_id="11" trp_db_name="NHLBI BioData Catalyst" trp_download_url="https://biodatacatalyst.nhlbi.nih.gov/resources/data" trp_help_url="https://biodatacatalyst.nhlbi.nih.gov/contact"><StudyFlags sam_with_min_meta="Yes" seq_data_to_ncbi="Yes" gen_phen_to_ncbi="Yes" has_out_ncbi_data="Yes"/></TrustedPartner></TrustedPartners></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>